Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Comprehensive molecular analysis of 26 newly established human pancreatic ductal adenocarcinoma cell lines reveals two clusters with variating drug sensitivities

Fig. 2

Genomic mutation profiles and contributions of signatures in pancreatic cancer cell lines A Overview of mutations in PDAC driver genes observed in our PCCLs (n = 26) compared with the mutational landscape in CCLE cell lines (n = 32). B Absolute contributions of mutational signatures identified across the PCCLs. C Absolute contributions of the two dominant signatures extracted from our cohort

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us